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Intr
Cardiac arrhythmias constitute a great challenge in the
ICU, since they aggravate a borderline cardiopulmonary
function. Atrial fibrillation (AF) forms the commonest
type of arrhythmias and an unappreciated chapter of the
respective literature at the same time.
Objectives
To estimate the prevalence of new onset AF in ICU
patients.
Methods
the study took place in a 13 level-3 bed ICU, of a uni-
versity hospital in Northwestern Greece, during Decem-
ber 2013-September 2014. All admitted patients were
scrutinized and their medical history, APACHE II score,
admission and discharge diagnosis, AF prevalence along
with arterial blood gases (ABGs) and vital signs during
the attack, arrhythmia´s treatment outcome and any
possible damaging factors responsible for its appearance
were recorded.
Results
A total of 192 patients were admitted during the study
period (124 men, 68 women, mean age 59.2 and 59.8 years
respectively). Total mortality was 27.6%, mean ICU staying
was 15 days (1-77 days). Twelve patients had history of
chronic AF (CAF) and 7 had history of paroxysmic AF
(PAF). During hospitalization, 37 patients developed rapid
ventricular response AF (RVAF, 7/12-58.33% with CAF,
4/7-57.14% with PAF and 18/173-10.4% with no history of
arrhythmias). Main factors for RVAF, common in all three
groups, were hypoxemia, sepsis and septic shock, severe
electrolyte abnormalities and APACHE II score above 30.
Amiodarone (300 mg in 30 minute infusion, followed by
either 900 mg in 24-hour infusion or 300 mg tid) was the
drug of choice in 32/37 patients, while in 5/37 patients (all
with CAF and RVAF), iv b-blocker was initially adminis-
tered. In 4/5 with CAF and RVAF, b-blocker was ineffec-
tive and amiodarone was additionally administered. In all
patients with CAF and RVAF, amiodarone was effective
for rate control. Amiodarone was also the drug of choice
for rhythm restoration in all RVAF and history of PAF and
those with no history of arrhythmias. Restoration of
rhythm was successful in all of those patients. In all cases,
RVAF improved quicker when the underlying condition
was hypoxemia, rather than sepsis or septic shock, while
electrolyte abnormalities rendered RVAF especially resis-
tant to treatment, until those abnormalities were effectively
addressed. Moreover, CAF patients were proven more dif-
ficult to respond to drugs than PAF ones. In most cases,
initial 300 mg of amiodarone sufficed for RVAF control.
Conclusions
RVAF is frequent in ICU patients, especially among those
with prior history of cardiac disease. Proper treatment
requires immediate control of the predisposing factor and
drug regimen initiation, mainly amiodarone.
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